
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden
Tao Qing, Hussein Mohsen, Michał Marczyk, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 82
Tao Qing, Hussein Mohsen, Michał Marczyk, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 82
Showing 26-50 of 82 citing articles:
Recent Advances in Pediatric Cancer Research
Troy A. McEachron, Lee J. Helman
Cancer Research (2021) Vol. 81, Iss. 23, pp. 5783-5799
Open Access | Times Cited: 17
Troy A. McEachron, Lee J. Helman
Cancer Research (2021) Vol. 81, Iss. 23, pp. 5783-5799
Open Access | Times Cited: 17
Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency
Kissy Guevara‐Hoyer, Jesús Fuentes‐Antrás, E. de la Fuente, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Kissy Guevara‐Hoyer, Jesús Fuentes‐Antrás, E. de la Fuente, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Hyunju Lee, Hee-Jeong Choi, Yoo Joo Jeong, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131925-131925
Open Access | Times Cited: 2
Hyunju Lee, Hee-Jeong Choi, Yoo Joo Jeong, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131925-131925
Open Access | Times Cited: 2
Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma
Eun Seop Seo, Ji Won Lee, Jinyeong Lim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Eun Seop Seo, Ji Won Lee, Jinyeong Lim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
Lauren G. Aoude, Vanessa Bonazzi, Sandra Brosda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Lauren G. Aoude, Vanessa Bonazzi, Sandra Brosda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 18
A polygenic two-hit hypothesis for prostate cancer
Kathleen E. Houlahan, Julie Livingstone, Natalie S. Fox, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 4, pp. 468-472
Open Access | Times Cited: 6
Kathleen E. Houlahan, Julie Livingstone, Natalie S. Fox, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 4, pp. 468-472
Open Access | Times Cited: 6
The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival
Chao Wang, Chun Liang
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Chao Wang, Chun Liang
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Considering hormone-sensitive cancers as a single disease in the UK biobank reveals shared aetiology
Muktar Beshir Ahmed, Ville‐Petteri Mäkinen, Anwar Mulugeta, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Muktar Beshir Ahmed, Ville‐Petteri Mäkinen, Anwar Mulugeta, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients
Jie Yang, Hefei Li, Ben Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Jie Yang, Hefei Li, Ben Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer
Michael W. Lewis, Kamila Wiśniewska, Caitlin M. King, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1852-1852
Open Access | Times Cited: 8
Michael W. Lewis, Kamila Wiśniewska, Caitlin M. King, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1852-1852
Open Access | Times Cited: 8
Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer
Xi Zhang, Rui Chen, Zirong Huo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xi Zhang, Rui Chen, Zirong Huo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree
Jinyu Gao, Yongzhang Wu, Jieming Yu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 13
Open Access | Times Cited: 1
Jinyu Gao, Yongzhang Wu, Jieming Yu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 13
Open Access | Times Cited: 1
Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes
Enrico Attardi, Lucia Tiberi, Giorgio Mattiuz, et al.
HemaSphere (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
Enrico Attardi, Lucia Tiberi, Giorgio Mattiuz, et al.
HemaSphere (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
Advancing environmental epidemiologic methods to conform the cancer burden
Rebecca D. Kehm, Susan E. Lloyd, Kimberly Burke, et al.
American Journal of Epidemiology (2024)
Open Access | Times Cited: 1
Rebecca D. Kehm, Susan E. Lloyd, Kimberly Burke, et al.
American Journal of Epidemiology (2024)
Open Access | Times Cited: 1
Selection bias as an explanation for the observed protective association of childhood adiposity with breast cancer
C. Mary Schooling, Kezhen Fei, Jie Zhao
Journal of Clinical Epidemiology (2023) Vol. 164, pp. 104-111
Open Access | Times Cited: 3
C. Mary Schooling, Kezhen Fei, Jie Zhao
Journal of Clinical Epidemiology (2023) Vol. 164, pp. 104-111
Open Access | Times Cited: 3
New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Young Kyung Ko, Jeong‐An Gim
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1539-1539
Open Access | Times Cited: 5
Young Kyung Ko, Jeong‐An Gim
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1539-1539
Open Access | Times Cited: 5
Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition
Marisa Schmitt, Tobias Sinnberg, Katrin Bratl, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100163-100163
Open Access | Times Cited: 7
Marisa Schmitt, Tobias Sinnberg, Katrin Bratl, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100163-100163
Open Access | Times Cited: 7
Higher ATM expression in lymphoblastoid cell lines from centenarian compared with younger women
Adva Hadar, Irena Voinsky, Olga Parkhomenko, et al.
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1419-1424
Open Access | Times Cited: 4
Adva Hadar, Irena Voinsky, Olga Parkhomenko, et al.
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1419-1424
Open Access | Times Cited: 4
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer
Esteban Astiazaran‐Symonds, C. Edmund Graham, Jung Kim, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 4
Esteban Astiazaran‐Symonds, C. Edmund Graham, Jung Kim, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 4
Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level
Michael T. Zimmermann, Angela Mathison, Tim Stodola, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Michael T. Zimmermann, Angela Mathison, Tim Stodola, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Systems genetics analysis of oral squamous cell carcinoma susceptibility using the mouse model: current position and new perspective
Aysar Nashef, Nayrouz Qahaz, Imad Abu El‐Naaj, et al.
Mammalian Genome (2021) Vol. 32, Iss. 5, pp. 323-331
Closed Access | Times Cited: 5
Aysar Nashef, Nayrouz Qahaz, Imad Abu El‐Naaj, et al.
Mammalian Genome (2021) Vol. 32, Iss. 5, pp. 323-331
Closed Access | Times Cited: 5
Genomic Determinants of Homologous Recombination Deficiency across Human Cancers
Tao Qing, Xin‐Feng Wang, Tomi Jun, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4572-4572
Open Access | Times Cited: 4
Tao Qing, Xin‐Feng Wang, Tomi Jun, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4572-4572
Open Access | Times Cited: 4
Machine-Learning Algorithms Predict Breast Cancer Patient Survival From Uk Biobank Whole-Exome Sequencing Data
Bum‐Sup Jang, In Ah Kim
Biomarkers in Medicine (2021) Vol. 15, Iss. 16, pp. 1529-1539
Open Access | Times Cited: 4
Bum‐Sup Jang, In Ah Kim
Biomarkers in Medicine (2021) Vol. 15, Iss. 16, pp. 1529-1539
Open Access | Times Cited: 4
Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations
Zoe Guan, Ronglai Shen, Colin B. Begg
Human Heredity (2021) Vol. 86, Iss. 1-4, pp. 34-44
Open Access | Times Cited: 4
Zoe Guan, Ronglai Shen, Colin B. Begg
Human Heredity (2021) Vol. 86, Iss. 1-4, pp. 34-44
Open Access | Times Cited: 4
Cancer Relevance of Human Genes
Tao Qing, Hussein Mohsen, Vincent L. Cannataro, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 7, pp. 988-995
Open Access | Times Cited: 3
Tao Qing, Hussein Mohsen, Vincent L. Cannataro, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 7, pp. 988-995
Open Access | Times Cited: 3